JRJohn J Ross

John J Ross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John J Ross has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Kevin L Ard

    Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital , Boston, Massachusetts

    3 shared publications
  • Narath Carlile

    Department of Medicine, Brigham and Women’s Hospital , Boston, Massachusetts

    2 shared publications
  • Ann E Woolley

    Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School , Boston, Massachusetts , USA

    1 shared publication
  • Richard A Zuckerman

    Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth , Nashua, New Hampshire , USA

    1 shared publication
  • Sophia Koo

    Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School , Boston, Massachusetts , USA

    1 shared publication

Latest Publications

  • Open Access

    Increasing Length of the Babesia Season in New England in the Climate Change Era

    by John J Ross, Narath Carlile, Kevin L Ard

    In a retrospective cohort of 1130 patients with babesiosis over a period of 31 years, there was a marked expansion of the Babesia season over time, with an increase of 0.33 months per year (CI 0.27 to 0.39) in a generalized linear model. The mean number of months with patients developing symptomatic infection with Babesia microti rose from 2.2 before 2000 to 9.2 after 2015. In the climate change era, babesiosis should be considered in the differential diagnosis of patients presenting with fever and anemia outside of peak summer months.


  • Open Access

    Septic Arthritis of the Spinal Facet Joint: Review of 117 Cases

    by John J Ross, Kevin L Ard

    Septic arthritis of the spinal facet joints is increasingly recognized in the era of magnetic resonance imaging, but its epidemiology, clinical features, management, and prognosis are ill-defined. We review 101 previously published cases and report 16 cases occurring at our institutions between 2006 and 2018. Most patients presented with fever (60%) and back or neck pain (86%). Radiation into the hip, buttock, or limb was present in 34%. The lumbosacral vertebral segments were involved in 78% of cases. Most cases (64%) were due to Staphylococcus aureus. Bacteremia was present in 66% and paraspinal muscle abscesses in 54%. While epidural abscesses were present in 56%, neurologic complications were seen in only 9%, likely because most abscesses arose below the conus medullaris. Neurologic complications were more common with cervical or thoracic involvement than lumbosacral (32% vs 2%, P < .0001). Extraspinal infection, such as endocarditis, was identified in only 22% of cases. An overall 98% of patients survived, with only 5% having neurologic sequelae. Septic arthritis of the facet joint is a distinct clinical syndrome typically involving the lumbar spine and is frequently associated with bacteremia, posterior epidural abscesses, and paraspinal pyomyositis. Neurologic outcomes are usually good with medical management alone.


  • Open Access

    Blastomycosis in New England: 5 Cases and a Review

    by John J Ross, Sophia Koo, Ann E Woolley, Richard A Zuckerman

    The geographic range of blastomycosis is thought to include New England, but documentation is sparse. We report five cases of infection with Blastomyces dermatitidis which were likely acquired in New England between 2011 and 2021. Our experience suggests that chart coding for the diagnosis of blastomycosis is imprecise, and that mandatory reporting might help resolve uncertainties about the prevalence and extent of blastomycosis.


  • Open Access

    Septic Arthritis and the Opioid Epidemic: 1465 Cases of Culture-Positive Native Joint Septic Arthritis From 1990–2018

    by John J Ross, Kevin L Ard, Narath Carlile

    The clinical spectrum of septic arthritis in the era of the opioid crisis is ill-defined. Retrospective chart review of 1465 cases of culture-positive native joint septic arthritis at Boston teaching hospitals between 1990 and 2018. Between 1990-2008 and 2009-2018, the proportion of septic arthritis cases involving people who inject drugs (PWID) rose from 10.3% to 20% (P < 0.0000005). Overall, methicillin-sensitive Staphylococcus aureus (MSSA) caused 41.5% of cases, and methicillin-resistant Staphylococcus aureus (MRSA) caused 17.9%. Gram-negative rods caused only 6.2% of cases. Predictors of MRSA septic arthritis included IDU (P < 0.001), bacteremia (P < 0.001), healthcare exposure (P < 0.001), and advancing age (P = 0.01). Infections with MSSA were more common in PWID (56.3% vs 38.8%, P < 0.00001), as were infections with MRSA (24% vs 16.8%, P = 0.01) and Serratia sp. (4% vs 0.4%, P = 0.002). Septic arthritis in the setting of injection drug use (IDU) was significantly more likely to involve the sacroiliac, acromioclavicular, and facet joints. 36.8% of patients had initial synovial fluid cell counts of < 50,000 cells/mm3. Injection drug use has become the most common risk factor for septic arthritis in our patient population. Septic arthritis in PWID is more often caused by MRSA, MSSA, and Serratia sp., and is more prone to involve the sacroiliac, acromioclavicular, sternoclavicular, and facet joints. Synovial fluid cell counts of < 50,000 cells/mm3 are common in culture-positive septic arthritis.